{"id":"W4392246465","doi":"10.1016/j.esmoop.2024.102273","title":"44O Updated results from a phase I study evaluating the KRAS G12C inhibitor MK-1084 in solid tumors and in combination with pembrolizumab in NSCLC","year":2024,"lang":"en","type":"article","venue":"ESMO Open","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; McMaster University","funders":"","keywords":"KRAS; Pembrolizumab; Medicine; Cancer research; Internal medicine; Oncology; Cancer; Colorectal cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005183373,0.0007292716,0.001960892,0.001106502,0.0004177325,0.002352792,0.001023214,0.0009341416,0.006608061],"category_scores_gemma":[0.0066429,0.0004630293,0.002031208,0.001909255,0.0002011207,0.0008555843,0.0006977285,0.001153338,0.00192298],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001674465,"about_ca_system_score_gemma":0.00320926,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005351499,"about_ca_topic_score_gemma":0.01334614,"domain_scores_codex":[0.9973451,0.0007774092,0.0003607997,0.0002043061,0.0009994612,0.0003129518],"domain_scores_gemma":[0.9936632,0.001370851,0.001809867,0.0004607765,0.002073916,0.0006214363],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1187878,0.00363084,0.08725725,0.01000955,0.01000802,0.001167708,0.0003688591,0.005721581,0.06107915,0.0004234834,0.1476106,0.5539352],"study_design_scores_gemma":[0.0249357,0.03705033,0.4461276,0.001251533,0.02901377,0.00309531,0.0002360688,0.001323459,0.03340071,0.0007306506,0.4225567,0.0002781602],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5397,0.1018637,0.00609249,0.006801962,0.002493346,0.003924611,0.2747927,0.001810389,0.06252084],"genre_scores_gemma":[0.5882477,0.03372966,0.01264979,0.009760829,0.001591741,0.002419651,0.3299627,0.0007295205,0.02090846],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006608061,"threshold_uncertainty_score":0.02741259,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04750845522952496,"score_gpt":0.4015019755190461,"score_spread":0.3539935202895211,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}